Koyfin Home > Directory > Health Care > Amag Pharmaceuticals > Cash from Investing Activities

Amag Pharmaceuticals Cash from Investing Activities Chart (AMAG)

Amag Pharmaceuticals annual/quarterly Cash from Investing Activities from 2010 to 2020.
  • Amag Pharmaceuticals Cash from Investing Activities for the quarter ending June 06, 2020 was $40m a 152.72% increase of 62m year over year
  • Amag Pharmaceuticals Cash from Investing Activities for the last 12 months ending June 06, 2020 was $21m a 112.29% increase of 24m year over year
  • Amag Pharmaceuticals Annual Cash from Investing Activities for 2019 was $21m a -2,295.55% decrease of -481m from 2018
  • Amag Pharmaceuticals Annual Cash from Investing Activities for 2018 was $502m a 79.50% increase of 399m from 2017
  • Amag Pharmaceuticals Annual Cash from Investing Activities for 2017 was $103m a 170.64% increase of 176m from 2016
Other Cash Flow Metrics:
  • Amag Pharmaceuticals Cash Flow from Operations for the quarter ending December 12, 2018 was $-34m a 162.36% decrease of -55m year over year
  • Amag Pharmaceuticals Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-31m a 66.13% decrease of -21m year over year
  • Amag Pharmaceuticals Total Revenue for the quarter ending September 09, 2018 was $122m a -29.53% decrease of -36m year over year
View Chart On Koyfin

Quarterly AMAG Cash from Investing Activities Data

06/2020$40m
03/2020$-11m
12/2019$13m
09/2019$-21m
06/2019$18m
03/2019$11m
12/2018$-11m
09/2018$517m
03/2018$-4m
12/2017$-3m

Annual AMAG Cash from Investing Activities Data

2019$21m
2018$502m
2017$103m
2016$-73m
2015$-899m
2014$-433m
2013$-14m
2012$-16m
2011$14m
2010$-104m